tradingkey.logo

Tempus AI Inc

TEM
View Detailed Chart

52.900USD

-0.600-1.12%
Close 04/25, 16:00ETQuotes delayed by 15 min
8.58BMarket Cap
LossP/E TTM

Tempus AI Inc

52.900

-0.600-1.12%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.12%

5 Days

+30.78%

1 Month

0.00%

6 Months

0.00%

Year to Date

0.00%

1 Year

0.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 12 analysts
BUY
Current Rating
62.111
Target Price
17.41%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

556
Total
5
Median
6
Average
Company name
Ratings
Analysts
Tempus AI Inc
TEM
12
CRISPR Therapeutics AG
CRSP
29
Regeneron Pharmaceuticals Inc
REGN
28
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Moderna Inc
MRNA
27
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(0)
Neutral(0)
Buy(2)
Indicators
Sell(0)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
--
--
RSI(14)
--
--
STOCH(KDJ)(9,3,3)
--
--
ATR(14)
--
--
CCI(14)
--
--
Williams %R
--
--
TRIX(12,20)
--
--
StochRSI(14)
--
--
Moving Average
Sell(0)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
--
--
MA10
--
--
MA20
--
--
MA50
--
--
MA100
--
--
MA200
--
--

News

More news coming soon, stay tuned...

Company

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Company codeTEM
CompanyTempus AI Inc
CEOMr. Eric P. Lefkofsky
Websitehttps://www.tempus.com/